Dean Investment Associates, LLC Amgen Inc Transaction History

Dean Investment Associates, LLC

$726 Million
Q3 2024

A detailed history of Dean Investment Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dean Investment Associates, LLC holds 15,266 shares of AMGN stock, worth $4.03 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

15,266

Previous 15,715 2.86%

Holding current value

$4.03 Million

Previous $4.91 Million 0.16%

% of portfolio

0.68%

Previous 0.7%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$309.38 - $337.38 $138,911 - $151,483	-449 Reduced 2.86%	15,266 $4.92 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $382,301 - $464,596	-1,455 Reduced 8.47%	15,715 $4.91 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $1.85 Million - $2.23 Million	-6,864 Reduced 28.56%	17,170 $4.88 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $1.88 Million - $2.12 Million	-7,359 Reduced 23.44%	24,034 $6.92 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $33,016 - $40,990	-151 Reduced 0.48%	31,393 $8.44 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $7,713 - $9,121	36 Added 0.11%	31,544 $7 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.14 Million - $1.39 Million	5,038 Added 19.03%	31,508 $7.62 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $502,720 - $638,766	2,195 Added 9.04%	26,470 $6.95 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $2.56 Million - $2.88 Million	11,384 Added 88.31%	24,275 $5.47 Million
Q2 2022 Aug 18, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.23%	12,891 $3.14 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $71,262 - $78,835	325 Added 2.58%	12,921 $3.13 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $68,215 - $78,066	-343 Reduced 2.65%	12,596 $2.83 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $48,397 - $56,703	228 Added 1.79%	12,939 $2.75 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $29,431 - $32,651	126 Added 1.0%	12,711 $3.1 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $109,704 - $130,638	-507 Reduced 3.87%	12,585 $2.89 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $40,829 - $45,405	-174 Reduced 1.31%	13,092 $3.33 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $833,966 - $1.02 Million	-4,216 Reduced 24.12%	13,266 $3.13 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $114,446 - $151,787	-628 Reduced 3.47%	17,482 $3.54 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $46,356 - $59,584	-245 Reduced 1.33%	18,110 $4.37 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $124,488 - $149,163	715 Added 4.05%	18,355 $3.55 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $61,678 - $72,301	370 Added 2.14%	17,640 $3.25 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $72,528 - $81,755	401 Added 2.38%	17,270 $3.28 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $296,679 - $346,319	1,663 Added 10.94%	16,869 $3.28 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $278,861 - $314,379	1,505 Added 10.98%	15,206 $3.15 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $45,829 - $51,476	-276 Reduced 1.97%	13,701 $2.53 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $404,598 - $472,824	2,388 Added 20.61%	13,977 $2.38 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $56,375 - $62,989	334 Added 2.97%	11,589 $2.02 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $1.88 Million - $2.15 Million	11,255	11,255 $2.1 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Investment Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dean Investment Associates, LLC with notifications on news.

Account

Dean Investment Associates, LLC Amgen Inc Transaction History